PhRMA Prepares To Make Case For “FDA Defense” In Malpractice Bill

A U.S. Chamber of Commerce survey on the impact of prescription drug product liability litigation could help the pharmaceutical industry shore up its case for inclusion of "FDA defense" language in any medical malpractice legislation enacted into law

More from Archive

More from Pink Sheet